Sept 2 General Electric Co's healthcare
unit last week won U.S. Food and Drug Administration approval
for its mammography device that produces three-dimensional
images to detect breast cancer.
According to the company's website, the device, SenoClaire,
uses imaging technology that combines low radiation-dosed X-rays
from multiple angles to produce a superior mammogram.
The device consists of hardware and software upgrades to the
company's previously launched Senographe Essential 2D full-field
digital mammography system.
The hardware upgrade produces multiple, low-dose x-ray
projection images of the breast. The software upgrade uses the
low-dose X-ray images to create cross-sectional views of the
Hologic Inc came up with one of the first 3-D
breast imaging devices in 2001, which continues to dominate the
market. Siemens AG submitted its application for the
approval of its own 3-D breast imaging device in June.
(Reporting by Amrutha Penumudi in Bangalore; Editing by Lisa